Liothyronine sodium and Flatulence - a phase IV clinical study of FDA data

Summary:

Flatulence is reported as a side effect among people who take Liothyronine sodium (liothyronine sodium), especially for people who are female, 60+ old, also take Sandostatin, and have Adenoma benign.

The phase IV clinical study analyzes which people have Flatulence when taking Liothyronine sodium. It is created by eHealthMe based on reports of 3,806 people who have side effects when taking Liothyronine sodium from the FDA, and is updated regularly.

What is Liothyronine sodium?

Liothyronine sodium has active ingredients of liothyronine sodium. It is often used in hypothyroidism. eHealthMe is studying from 4,275 Liothyronine sodium users. Check the latest studies of Liothyronine sodium.

What is Flatulence?

Flatulence (flatus expelled through the anus) is found to be associated with 1,757 drugs and 1,892 conditions by eHealthMe. Check the latest studies of Flatulence.

On Jul, 15, 2026

3,806 people reported to have side effects when taking Liothyronine sodium.
Among them, 14 people (0.37%) have Flatulence.

Could Liothyronine sodium cause Flatulence?

Among these 14 people:

What is the gender of people who have Flatulence when taking Liothyronine sodium? *

female: 100 %
male: 0.0 %

What is the age of people who have Flatulence when taking Liothyronine sodium? *

What are other drugs people take besides Liothyronine sodium? *

What are other side effects people have besides Flatulence? *

Abdominal Distension: 8 people, 57.14%
Fatigue (feeling of tiredness): 7 people, 50.00%
Weakness: 7 people, 50.00%
Muscle Aches (muscle pain): 6 people, 42.86%
Nausea (feeling of having an urge to vomit): 6 people, 42.86%
Diarrhea: 5 people, 35.71%
Blood Glucose Decreased: 5 people, 35.71%
Chalazion (cyst in the eyelid): 4 people, 28.57%
Neoplasm Progression (growth of tumour): 4 people, 28.57%
Injection Site Pain: 4 people, 28.57%

What are the existing conditions these people have? *

Adenoma Benign (non-cancerous tumour -secreting): 4 people, 28.57%
Thyroxine Decreased: 1 person, 7.14%
Post Procedural Hypothyroidism: 1 person, 7.14%
Pelvic Mass: 1 person, 7.14%
Pelvic Abscess: 1 person, 7.14%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 1 person, 7.14%
High Blood Cholesterol: 1 person, 7.14%
Diabetes: 1 person, 7.14%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 7.14%
Breast Cancer: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Liothyronine sodium and have Flatulence?

- Check whether Flatulence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Liothyronine sodium:

Liothyronine sodium (4,275 reports)

Flatulence treatments and more:

Flatulence (70,667 reports)

Browse all side effects of Liothyronine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Flatulence:

Flatulence (1,757 drugs)

Browse all the conditions that are associated with Flatulence:

Flatulence (1,892 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on liothyronine sodium (the active ingredients of Liothyronine sodium) and Liothyronine sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.